Jan Christop L. Merene

Array ( [id] => 4909200 [patent_doc_number] => 20080019966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'Monoclonal antibodies to hepatocyte growth factor' [patent_app_type] => utility [patent_app_number] => 11/818305 [patent_app_country] => US [patent_app_date] => 2007-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10806 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20080019966.pdf [firstpage_image] =>[orig_patent_app_number] => 11818305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 322420 [patent_doc_number] => 07517652 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'Methods of diagnosing tumors using the G-protein coupled receptor (GPCR), RAI-3' [patent_app_type] => utility [patent_app_number] => 11/809905 [patent_app_country] => US [patent_app_date] => 2007-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 53 [patent_no_of_words] => 95809 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517652.pdf [firstpage_image] =>[orig_patent_app_number] => 11809905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6549553 [patent_doc_number] => 20100016558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'CLONING AND RECOMBINANT PRODUCTION OF RECEPTOR(S) OF THE ACTIVIN/TGF-BETA SUPERFAMILY' [patent_app_type] => utility [patent_app_number] => 11/747869 [patent_app_country] => US [patent_app_date] => 2007-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11488 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016558.pdf [firstpage_image] =>[orig_patent_app_number] => 11747869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5385687 [patent_doc_number] => 20090226932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'Novel G Protein-Coupled Receptor' [patent_app_type] => utility [patent_app_number] => 11/747722 [patent_app_country] => US [patent_app_date] => 2007-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7884 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226932.pdf [firstpage_image] =>[orig_patent_app_number] => 11747722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5315483 [patent_doc_number] => 20090280081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'JAK/STAT pathway inhibitors and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/799128 [patent_app_country] => US [patent_app_date] => 2007-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 12369 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20090280081.pdf [firstpage_image] =>[orig_patent_app_number] => 11799128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9153153 [patent_doc_number] => 08586054 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-19 [patent_title] => 'Method for modulating, treating and/or preventing metabolic syndrome using MAS-G-protein-coupled receptor agonists' [patent_app_type] => utility [patent_app_number] => 12/298351 [patent_app_country] => US [patent_app_date] => 2007-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 12536 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12298351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5297058 [patent_doc_number] => 20090011984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Biotin-binding receptor molecules' [patent_app_type] => utility [patent_app_number] => 11/789739 [patent_app_country] => US [patent_app_date] => 2007-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3092 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20090011984.pdf [firstpage_image] =>[orig_patent_app_number] => 11789739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 326437 [patent_doc_number] => 07514208 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-07 [patent_title] => 'Methods for identifying modulators of cyclic nucleotide-gated cation channels' [patent_app_type] => utility [patent_app_number] => 11/736156 [patent_app_country] => US [patent_app_date] => 2007-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24321 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/514/07514208.pdf [firstpage_image] =>[orig_patent_app_number] => 11736156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6627687 [patent_doc_number] => 20100004166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Endothelin and Endothelin Receptor Agonists in the Treatment of Metabolic Diseases' [patent_app_type] => utility [patent_app_number] => 12/294235 [patent_app_country] => US [patent_app_date] => 2007-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10024 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004166.pdf [firstpage_image] =>[orig_patent_app_number] => 12294235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6222410 [patent_doc_number] => 20100056441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'Method for Inhibiting Angiogenesis' [patent_app_type] => utility [patent_app_number] => 12/282113 [patent_app_country] => US [patent_app_date] => 2007-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17655 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056441.pdf [firstpage_image] =>[orig_patent_app_number] => 12282113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5385684 [patent_doc_number] => 20090226929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'TITINIC ION CHANNEL, COMPOSITIONS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/225051 [patent_app_country] => US [patent_app_date] => 2007-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21659 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226929.pdf [firstpage_image] =>[orig_patent_app_number] => 12225051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8845776 [patent_doc_number] => 08454952 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Augmentation of endothelial thromboresistance' [patent_app_type] => utility [patent_app_number] => 12/282769 [patent_app_country] => US [patent_app_date] => 2007-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 33 [patent_no_of_words] => 12291 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12282769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5220256 [patent_doc_number] => 20070161567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Method of reducing the risk of bone fracture' [patent_app_type] => utility [patent_app_number] => 11/684996 [patent_app_country] => US [patent_app_date] => 2007-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18057 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161567.pdf [firstpage_image] =>[orig_patent_app_number] => 11684996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 177687 [patent_doc_number] => 07655395 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'Isolation and use of ryanodine receptors' [patent_app_type] => utility [patent_app_number] => 11/715725 [patent_app_country] => US [patent_app_date] => 2007-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 21849 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655395.pdf [firstpage_image] =>[orig_patent_app_number] => 11715725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8994529 [patent_doc_number] => 08518411 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Modified TGF-β superfamily protein' [patent_app_type] => utility [patent_app_number] => 11/715679 [patent_app_country] => US [patent_app_date] => 2007-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 32 [patent_no_of_words] => 33555 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11715679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5119930 [patent_doc_number] => 20070141644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Novel Receptors' [patent_app_type] => utility [patent_app_number] => 11/680133 [patent_app_country] => US [patent_app_date] => 2007-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24278 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20070141644.pdf [firstpage_image] =>[orig_patent_app_number] => 11680133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 348537 [patent_doc_number] => 07494650 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-24 [patent_title] => 'Monoclonal antibodies to hepatocyte growth factor' [patent_app_type] => utility [patent_app_number] => 11/710009 [patent_app_country] => US [patent_app_date] => 2007-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10830 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/494/07494650.pdf [firstpage_image] =>[orig_patent_app_number] => 11710009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398281 [patent_doc_number] => 20090318344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING HEMOSTASIS USING VARIANT FORMS OF ACTIVATED FACTOR V' [patent_app_type] => utility [patent_app_number] => 12/162935 [patent_app_country] => US [patent_app_date] => 2007-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12625 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318344.pdf [firstpage_image] =>[orig_patent_app_number] => 12162935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4988136 [patent_doc_number] => 20070154475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Novel polypeptides having sequence similarity to GDNFR and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 11/709185 [patent_app_country] => US [patent_app_date] => 2007-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 32807 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20070154475.pdf [firstpage_image] =>[orig_patent_app_number] => 11709185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4965743 [patent_doc_number] => 20080108563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Novel polypeptides having sequence similarity to GDNFR and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 11/708911 [patent_app_country] => US [patent_app_date] => 2007-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 32823 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108563.pdf [firstpage_image] =>[orig_patent_app_number] => 11708911 [rel_patent_id] =>[rel_patent_doc_number] =>)